AngioDynamics (ANGO) Stock Price, News & Analysis

Company Overview

AngioDynamics, Inc. (NASDAQ: ANGO) is a medical technology company that develops and manufactures minimally invasive devices used in vascular, oncology, and surgical procedures. Its products are designed to help physicians diagnose and treat vascular disease, remove or manage blood clots, and deliver targeted therapies for certain cancers and other conditions.

The company’s product portfolio includes the Auryon Atherectomy System for treating peripheral arterial disease, the AngioVac System for the removal of unwanted intravascular material, and the NanoKnife System, which uses irreversible electroporation to ablate soft-tissue tumors. AngioDynamics also offers devices for vascular access and other interventional procedures, including systems intended to support catheter placement and reduce complications.

Founded in 1988 and headquartered in Latham, New York, AngioDynamics sells its products through a combination of direct sales and distributors in the United States and international markets. The company serves hospitals, physicians, and other healthcare providers, with an emphasis on technologies that can be used in less invasive alternatives to traditional surgery.

Key Stats

• Today's Range: $15.00 to $15.64
• 50-Day Range: $13.44 to $16.13
• 52-Week Range: $9.39 to $16.29
• Volume: 497,477 shs
• Average Volume: 390,031 shs
• Market Capitalization: $635.45 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $19.50
• Consensus Rating: Hold

AngioDynamics Stock Analysis - MarketRank™

AngioDynamics scored higher than 74% of companies evaluated by MarketBeat, and ranked 178th out of 908 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.0 / 5
• Analyst Rating: Hold

Consensus Rating

AngioDynamics has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 1 strong buy rating, 2 buy ratings, no hold ratings, and 2 sell ratings.

Upside Potential

AngioDynamics has a consensus price target of $19.50, representing about 27.6% upside from its current price of $15.28.

Amount of Analyst Coverage

AngioDynamics has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for AngioDynamics are expected to grow in the coming year, from ($0.25) to ($0.17) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of AngioDynamics is -17.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of AngioDynamics is -17.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

AngioDynamics has a P/B Ratio of 3.70. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.46% of the float of AngioDynamics has been sold short.

Short Interest Ratio / Days to Cover

AngioDynamics has a short interest ratio ("days to cover") of 3.48, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in AngioDynamics has recently decreased by 1.48%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

AngioDynamics does not currently pay a dividend.

Dividend Growth

AngioDynamics does not have a long track record of dividend growth.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 0.47

News Sentiment

AngioDynamics has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for AngioDynamics this week, compared to 4 articles on an average week.

Search Interest

Only 1 people have searched for ANGO on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

MarketBeat Follows

2 people have added AngioDynamics to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.6 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, AngioDynamics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $344,006.00 in company stock.

Percentage Held by Insiders

6.00% of the stock of AngioDynamics is held by insiders.

Percentage Held by Institutions

89.43% of the stock of AngioDynamics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/14/2026
• Today: 9/25/2026
• Next Earnings (Estimated): 10/01/2026
• Fiscal Year End: 5/31/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:ANGO
• CIK: 1275187
• Web: www.angiodynamics.com
• Phone: (518) 795-1400
• Fax: 518-795-1401
• Employees: 632
• Year Founded: 1988

Price Target and Rating

• Average Price Target for AngioDynamics: $19.50
• High Price Target: $20.00
• Low Price Target: $19.00
• Potential Upside/Downside: +27.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.40
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.87)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$36.74 million
• Net Margins: -11.48%
• Pretax Margin: -11.34%
• Return on Equity: -5.73%
• Return on Assets: -3.77%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.19
• Quick Ratio: 1.49

Sales & Book Value

• Annual Sales: $320.17 million
• Price / Sales: 1.97
• Cash Flow: $0.30 per share
• Price / Cash Flow: 50.09
• Book Value: $4.13 per share
• Price / Book: 3.69

Miscellaneous

• Outstanding Shares: 41,330,000
• Free Float: 38,852,000
• Market Cap: $630.28 million
• Optionable: Optionable
• Beta: 0.33